Gilbert Halley E

CIK 00016013607 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001601360

Recent Transactions

50 trades

Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2026-06-17+59,000→ 59,000 total
Award
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2026-06-15+11,389→ 11,389 total
Award
Vaxcyte, Inc.$PCVX
Common Stock
2026-06-15+2,265→ 12,481 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2026-06-05+5,778→ 27,901 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Stock Option (right to buy)
2026-06-05+16,667→ 16,667 total
Exercise/Conversion
Arcutis Biotherapeutics, Inc.$ARQT
Stock Option (right to buy)
2025-11-20−12,220→ 0 total
Sale
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2025-11-20$27.55/sh−16,532→ 22,123 total
Exercise/Conversion
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2025-11-20$7.51/sh+12,220→ 38,655 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2025-06-12+7,609→ 26,435 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Stock Option (right to buy)
2025-06-12+20,568→ 20,568 total
Award
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2025-06-12+15,372→ 15,372 total
Award
Vaxcyte, Inc.$PCVX
Common Stock
2025-06-12+3,041→ 10,216 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2025-06-11+38,000→ 38,000 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2024-06-14+10,139→ 18,826 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Stock Option (right to buy)
2024-06-14+27,052→ 27,052 total
Award
Vaxcyte, Inc.$PCVX
Common Stock
2024-06-06+1,550→ 7,175 total
Award
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2024-06-06+7,250→ 7,250 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2024-06-03$73.00/sh−18,200→ 5,625 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Common Stock
2024-06-03$5.35/sh+18,200→ 23,825 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Stock Option (Right to Buy)
2024-06-03−18,200→ 30,374 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2024-05-15+38,000→ 38,000 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2023-06-14+25,000→ 25,000 total
Award
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2023-06-13+15,000→ 15,000 total
Award
Vaxcyte, Inc.$PCVX
Common Stock
2023-06-13+2,500→ 5,625 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Stock Option (right to buy)
2023-05-31+12,220→ 12,220 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2023-05-31+4,375→ 8,687 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2022-06-15+25,000→ 25,000 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Common Stock
2022-06-01+4,312→ 4,312 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Stock Option (Right to Buy)
2022-06-01+11,796→ 11,796 total
Award
Vaxcyte, Inc.$PCVX
Common Stock
2022-06-01+3,125→ 3,125 total
Award
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2022-06-01+18,750→ 18,750 total
Award
NEOGENOMICS INC$NEO
Stock Option (Right to Buy)
2022-03-01+102,623→ 102,623 total
Award
NEOGENOMICS INC$NEO
Common Stock
2022-03-01+42,036→ 147,396 total
Small Acquisition
NEOGENOMICS INC$NEO
Common Stock
2021-12-31$31.30/sh+177→ 105,263 total
Award
NEOGENOMICS INC$NEO
Common Stock
2021-12-30+45,858→ 105,086 total
Award
NEOGENOMICS INC$NEO
Common Stock
2021-08-17+63,331→ 63,331 total
Award
NEOGENOMICS INC$NEO
Common Stock
2021-08-17+59,228→ 59,228 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2021-06-16+20,000→ 20,000 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Stock Option (Right to Buy)
2021-06-09+13,391→ 13,391 total
Award
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2021-06-02−15,000→ 15,000 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2020-06-17+20,000→ 20,000 total
Award
Arcutis Biotherapeutics, Inc.$ARQT
Stock Option (Right to Buy)
2020-05-01+37,500→ 37,500 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2020-04-27+40,000→ 40,000 total
Sale
IRONWOOD PHARMACEUTICALS INC$IRWD
Class A Common Stock
2020-02-21$11.63/sh−2,753→ 278,566 total
Sale
IRONWOOD PHARMACEUTICALS INC$IRWD
Class A Common Stock
2020-02-21$11.63/sh−3,410→ 275,156 total
Sale
IRONWOOD PHARMACEUTICALS INC$IRWD
Class A Common Stock
2020-02-21$11.63/sh−6,181→ 265,991 total
Sale
IRONWOOD PHARMACEUTICALS INC$IRWD
Class A Common Stock
2020-02-21$11.63/sh−2,984→ 272,172 total
Disposition to Issuer
Dermira, Inc.
Director Stock Options (Right to buy)
2020-02-20−20,000→ 0 total
Exercise/Conversion
IRONWOOD PHARMACEUTICALS INC$IRWD
Class A Common Stock
2020-01-31$10.02/sh+60,000→ 341,319 total
Exercise/Conversion
IRONWOOD PHARMACEUTICALS INC$IRWD
Employee Stock Option (Right to Buy)
2020-01-31−60,000→ 0 total

Companies

Recent Filings

Address

C/O CYTOMX THERAPEUTICS, INC. 151 OYSTER POINT BLVD., STE. 400

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov